United States Biotechnology & Medical Research

Adial Pharmaceuticals Inc (ADIL)

Adial Pharmaceuticals Inc. recorded multiple buy transactions from Coastlands Capital LP between June 29 and July 16, 2026. These acquisitions represent the most recent insider trading activity. No further market movements occurred within the last three months, as the latest recorded purchase dates back to mid-July.
Ticker: ADIL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Adial Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Coastlands Capital LP Large shareholder
Transaction date
Purchase
Price
126.46
Quantity 20,660 +11.0%
Value US$4,513,799
2.6
Coastlands Capital LP Large shareholder
Transaction date
Purchase
Price
40.22
Quantity 99,605 -48.0%
Value US$1,149,939
2.6
Coastlands Capital LP Large shareholder
Transaction date
Purchase
Price
284.80
Quantity 91,808 -49.6%
Value US$2,824,563
2.6
Coastlands Capital LP Large shareholder
Transaction date
Purchase
Price
2.79
Quantity 10,053 +2.7%
Value US$28,048
2.6
Coastlands Capital LP Large shareholder
Transaction date
Purchase
Price
2.60
Quantity 25,000 +7.2%
Value US$65,000
2.2
Schuyler Kevin Non-Executive Director
Transaction date
Purchase
Price
2.74
Quantity 700 New position
Value US$1,918
1.6
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
2.71
Quantity 10,000 +40.6%
Value US$27,100
1.6
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
2.72
Quantity 5,000 +11.1%
Value US$13,600
1.6
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
2.66
Quantity 10,000 +100.0%
Value US$26,600
1.9
Stilley William B. III Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.75
Quantity 10,600 +1.1%
Value US$29,179
1.9
Stilley William B. III Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
2.59
Quantity 10,000 +1.1%
Value US$25,892
1.6
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
2.85
Quantity 10,000 +40.9%
Value US$28,500
1.3
Johnson Bankole A. Chief Medical Officer Officer
Transaction date
Sale
Price
0.00
Quantity 200,000
Value US$0
1.3
Johnson Bankole A. Chief Medical Officer Officer
Transaction date
Sale
Price
2.50
Quantity 150,000 -21.5%
Value US$375,000
1.3
Johnson Bankole A. Chief Medical Officer Officer
Transaction date
Sale
Price
1.21
Quantity 350,000 -99.7%
Value US$423,500
1.6
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
1.35
Quantity 4,644 +46.4%
Value US$6,269
1.6
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 10,000 +304.1%
Value US$13,400
1.6
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 5,000 +50.0%
Value US$7,100
1.9
Stilley William B. III Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.47
Quantity 12,652 +1.8%
Value US$18,598
1.9
Stilley William B. III Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
1.13
Quantity 12,348 +1.8%
Value US$13,953
Johnson Bankole A. Chief Medical Officer Officer Large shareholder
Transaction date
Sale
Price
1.00
Quantity 150,000 -17.7%
Value US$150,000
1.3
Johnson Bankole A. Chief Medical Officer Large shareholder
Transaction date
Purchase
Price
3.30
Quantity 600 +0.2%
Value US$1,978
1.3
Johnson Bankole A. Chief Medical Officer Large shareholder
Transaction date
Purchase
Price
3.47
Quantity 2,500 +0.7%
Value US$8,669
1.3
Johnson Bankole A. Chief Medical Officer Large shareholder
Transaction date
Purchase
Price
3.47
Quantity 30,000 +9.5%
Value US$104,154
1.3
Johnson Bankole A. Chief Medical Officer Large shareholder
Transaction date
Purchase
Price
3.15
Quantity 40,000 +14.6%
Value US$125,808
Goodman Tony Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 7,000
Value US$0
Johnson Bankole A. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 1,400
Value US$0
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 10,000
Value US$0
Newman James W. Jr. Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 10,000
Value US$0
Stilley William B. III Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 80,000
Value US$0
Gilliland Robertson H. Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 14,000
Value US$0
Schuyler Kevin Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 90,000
Value US$0
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-16 B Purchase
2.6
Coastlands Capital LP
Large shareholder
20,660 +11.0%
126.46
US$4,513,799 		20,660 +11.0% 126.46 US$4,513,799
2026-07-16 2026-07-14 B Purchase
2.6
Coastlands Capital LP
Large shareholder
99,605 -48.0%
40.22
US$1,149,939 		99,605 -48.0% 40.22 US$1,149,939
2026-07-13 2026-07-10 B Purchase
2.6
Coastlands Capital LP
Large shareholder
91,808 -49.6%
284.80
US$2,824,563 		91,808 -49.6% 284.80 US$2,824,563
2026-07-13 2026-07-09 B Purchase
2.6
Coastlands Capital LP
Large shareholder
10,053 +2.7%
2.79
US$28,048 		10,053 +2.7% 2.79 US$28,048
2026-07-01 2026-06-29 B Purchase
2.6
Coastlands Capital LP
Large shareholder
25,000 +7.2%
2.60
US$65,000 		25,000 +7.2% 2.60 US$65,000
2023-10-03 2023-09-29 B Purchase
2.2
Schuyler Kevin
Non-Executive Director
700 New position
2.74
US$1,918 		700 New position 2.74 US$1,918
2022-01-03 2021-12-30 B Purchase
1.6
Newman James W. Jr.
Non-Executive Director
10,000 +40.6%
2.71
US$27,100 		10,000 +40.6% 2.71 US$27,100
2022-01-03 2021-12-30 B Purchase
1.6
Newman James W. Jr.
Non-Executive Director
5,000 +11.1%
2.72
US$13,600 		5,000 +11.1% 2.72 US$13,600
2022-01-03 2021-12-30 B Purchase
1.6
Newman James W. Jr.
Non-Executive Director
10,000 +100.0%
2.66
US$26,600 		10,000 +100.0% 2.66 US$26,600
2021-12-01 2021-11-30 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
10,600 +1.1%
2.75
US$29,179 		10,600 +1.1% 2.75 US$29,179
2021-12-01 2021-11-29 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
10,000 +1.1%
2.59
US$25,892 		10,000 +1.1% 2.59 US$25,892
2021-11-30 2021-11-26 B Purchase
1.6
Newman James W. Jr.
Non-Executive Director
10,000 +40.9%
2.85
US$28,500 		10,000 +40.9% 2.85 US$28,500
2021-10-06 2021-10-04 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
200,000
0.00
US$0 		200,000 0.00 US$0
2021-04-08 2021-04-06 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
150,000 -21.5%
2.50
US$375,000 		150,000 -21.5% 2.50 US$375,000
2020-08-24 2020-08-20 S Sale
1.3
Johnson Bankole A.

Chief Medical Officer

Officer
350,000 -99.7%
1.21
US$423,500 		350,000 -99.7% 1.21 US$423,500
2020-03-30 2020-03-27 B Purchase
1.6
Newman James W. Jr.
Non-Executive Director
4,644 +46.4%
1.35
US$6,269 		4,644 +46.4% 1.35 US$6,269
2020-03-30 2020-03-27 B Purchase
1.6
Newman James W. Jr.
Non-Executive Director
10,000 +304.1%
1.34
US$13,400 		10,000 +304.1% 1.34 US$13,400
2020-03-30 2020-03-27 B Purchase
1.6
Newman James W. Jr.
Non-Executive Director
5,000 +50.0%
1.42
US$7,100 		5,000 +50.0% 1.42 US$7,100
2020-03-27 2020-03-26 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
12,652 +1.8%
1.47
US$18,598 		12,652 +1.8% 1.47 US$18,598
2020-03-27 2020-03-25 B Purchase
1.9
Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
12,348 +1.8%
1.13
US$13,953 		12,348 +1.8% 1.13 US$13,953
2019-12-13 2019-12-12 S Sale Johnson Bankole A.

Chief Medical Officer

Officer Large shareholder
150,000 -17.7%
1.00
US$150,000 		150,000 -17.7% 1.00 US$150,000
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
600 +0.2%
3.30
US$1,978 		600 +0.2% 3.30 US$1,978
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
2,500 +0.7%
3.47
US$8,669 		2,500 +0.7% 3.47 US$8,669
2019-04-01 2019-03-29 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
30,000 +9.5%
3.47
US$104,154 		30,000 +9.5% 3.47 US$104,154
2019-04-01 2019-03-28 B Purchase
1.3
Johnson Bankole A.

Chief Medical Officer

Large shareholder
40,000 +14.6%
3.15
US$125,808 		40,000 +14.6% 3.15 US$125,808
2018-08-02 2018-07-31 B Purchase Goodman Tony Non-Executive Director
7,000
0.00
US$0 		7,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Johnson Bankole A. Non-Executive Director Large shareholder
1,400
0.00
US$0 		1,400 0.00 US$0
2018-08-02 2018-07-31 B Purchase Newman James W. Jr. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Newman James W. Jr. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Stilley William B. III

Chief Executive Officer

Executive Director Large shareholder
80,000
0.00
US$0 		80,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Gilliland Robertson H. Non-Executive Director
14,000
0.00
US$0 		14,000 0.00 US$0
2018-08-02 2018-07-31 B Purchase Schuyler Kevin Non-Executive Director
90,000
0.00
US$0 		90,000 0.00 US$0
Explore more

More insider trading research around Adial Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America